MGH’s associate chief of infectious disease, who’s working to find new approaches to fight drug-resistant superbugs, discusses how he treated one of the most notorious: NDM-1.
Readers weigh in on the challenges of medical literacy and issues with replicating research.
A Winning Formula?
Where do scientific prizes fit in the research funding landscape?
When Lyme Lingers
In most cases, antibiotics do the trick. But when they don't, symptoms can be devastating. New research aims to discover why.